PSYCH up2date, Table of Contents PSYCH up2date 2013; 7(05): 285-300DOI: 10.1055/s-0033-1349532 Abhängigkeitserkrankungen Tabakabhängigkeit und -entwöhnung bei psychiatrischen Patienten Anil Batra Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 Statistisches Bundesamt. Raucher und Nichtraucher. 2009. http://de.statista.com/statistik/daten/studie/157730/umfrage/raucher-und-nichtraucher-in-deutschland-2009/ 2 Donny EC, Dierker LC. The absence of DSM-IV nicotine dependence in moderate-to-heavy daily smokers. Drug and Alcohol Dependence 2007; 89: 93-96 3 Hoch E, Muehlig S, Hoefler M. et al. How prevalent is smoking and nicotine dependence in primary care in Germany?. Addiction 2004; 99: 1586-1598 4 Hughes JR, Helzer JE, Lindberg S. Prevalence of DSM/ICD-defined nicotine dependence. Drug and Alcohol Dependence 2006; 85: 91-102 5 Heatherton TF, Kozlowski LT, Frecker RC. et al. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addiction 1991; 86: 1119-1127 6 Fagerström KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addictive Behav 1978; 3: 235-241 7 Heatherton TF, Kozlowski LT, Frecker RC. et al. Measuring the heaviness of smoking using self-reported time to first cigarette of the day and number of cigarettes smoked per day. Br J Addiction 1989; 84: 791-800 8 Etter JF, Le Houezec J, Perneger TV. A self-administered questionnaire to measure dependence on cigarettes: The Cigarette Dependence Scale. Neuropsychopharmacol 2003; 28: 359-370 9 Batra A. Tabakabhängigkeit und Raucherentwöhnung bei psychiatrischen Patienten. Fortschr Neurol Psychiatrie 2000; 68: 80-92 10 Tanriover O, Karamustafaioglou N, Tezvaran Z. et al. Frequency of cigarette smoking among psychiatric inpatients evaluated by the Fagerström Test for Nicotine Dependence. Asian Pac J Cancer Prev 2013; 14: 579-582 11 Pedersen W, van Soest T. Smoking, nicotine dependence and mental health among young adults: A 13-year population-based longitudinal study. Addiction 2009; 104: 129-137 12 Royal College of Physicians, Royal College of Psychiatrists. Smoking and mental health. London: RCP; 2013 13 Lasser K, Boyd JW, Woolhandler S. et al. Smoking and mental illness: A population-based prevalence study. J Am Med Assoc 2000; 284: 2606-2610 14 Batra A. Tabakabhängigkeit – Biologische und psychosoziale Entstehungsbedingungen und Therapiemöglichkeiten. Darmstadt: Steinkopff; 2000 15 Heinz A, Batra A, Schwerbaum N, Gouzoulis-Mayfrank E. Neurobiologie der Abhängigkeit: Grundlagen und Konsequenzen für Diagnose und Therapie von Suchterkrankungen. Stuttgart: Kohlhammer; 2012 16 John U, Hanke M. Tobacco smoking- and alcohol drinking-attributable cancer mortality in Germany. Eur J Cancer Prev 2002; 11: 11-17 17 Kisely S, Sadek J, MacKenzie A. et al. Excess cancer mortality in psychiatric patients. Can J Psychiatry 2008; 53: 753-761 18 Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease: Public Health Research, Practice and Policy 2006; 3: A42 19 Kerr S, Woods C, Knussen C. et al. Breaking the habit: a qualitative exploration of barriers and facilitators to smoking cessation in people with enduring mental health problems. BMC Public Health 2013; 13: 221 20 Fiore MC, Jaén CR, Baker TB. Treating tobacco use and dependence: 2008 update (Clinical Practice Guideline). Rockville, MD: U.S. Department of Health and Human Services; 2008 21 Arzneimittelkommission der Deutschen Ärzteschaft. Empfehlungen zur Therapie der Tabakabhängigkeit. Arzneiverordnungen in der Praxis 2010; Sonderheft 2, Band 37: 0 22 Batra A, Schütz CG, Lindinger P. Tabakabhängigkeit. In: Schmidt LG, Gastpar M, Falkai P, Gaebel W. Hrsg. Evidenzbasierte Suchtmedizin. Behandlungsleitlinie Substanzbezogene Störungen. Köln: Deutscher Ärzte-Verlag; 2006: 91-142 23 Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews 2005; (02) Chichester, UK: John Wiley & Sons, Ltd.; DOI:. 24 Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews: Reviews 2005; (02) Chichester, UK: John Wiley & Sons, Ltd.; DOI:. 25 Stead LF, Perera R, Bullen C. et al. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews. 2008; (01) Chichester, UK: John Wiley & Sons, Ltd.; DOI: 26 Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews: Reviews 2007; (01) Chichester, UK: John Wiley & Sons, Ltd.; DOI:. 27 Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2008; (03) Chichester, UK: John Wiley & Sons, Ltd.; DOI:. 28 Niaura R, Britt DM, Shadel WG. et al. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav 2001; 15: 13-17 29 Cinciripini PM, Wetter DW, Fouladi RT. et al. The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. J Consult Clin Psychol 2003; 71: 292-301 30 Haas AL, Munoz RF, Humfleet GL. et al. Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clin Psychol 2004; 72: 563-570 31 Gierisch JM, Bastian LA, Calhoun PS. et al. Smoking cessation interventions for patients with depression: a systematic review and meta-analysis. J Gen Intern Med 2012; 27: 351-360 32 Hitsman B, Papandonatos GD, McChargue DE. et al. Past major depression and smoking cessation outcome: a systematic review and meta-analysis update. Addiction 2012; 108: 294-306 33 Batra A, Collins SE, Schröter M. et al. A Cluster-randomised Trial of Smoking Cessation Tailored to Multidimensional Smoker Profiles. J Subst Abuse Treatment 2010; 38: 128-140 34 Torchalla I, Schröter M, Batra A. Individualisierte Tabakentwöhnung. Stuttgart: Kohlhammer; 2013 35 Hall SM, Prochaska JJ. Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annu Rev Clin Psychol 2009; 5: 409-431 36 Tsoi DT, Porwal M, Webster AC. Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: a systematic review and meta-analysis. Br J Psychiatry 2010; 196: 346-353 37 Purvis TL, Nelson LA, Mambourg SE. Varenicline use in patients with mental illness: an update of the evidence. Expert Opin Drug Saf 2010; 9: 471-482 38 Batra A, Niethammer S, Mänz C. et al. Tabakentwöhnung bei stationären Patienten mit einer Alkoholabhängigkeit – Motivationsfaktoren und Erfolgsaussichten. Sucht 2011; 57: 337-346
